# Brain Response to Serotonergic Medications in ASD

> **NCT04145076** · NA · UNKNOWN · sponsor: **King's College London** · enrollment: 100 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** Citalopram
- **DRUG:** Tianeptine

## Key facts

- **NCT ID:** NCT04145076
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12-15
- **Primary completion:** 2023-02
- **Final completion:** 2023-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04145076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04145076, "Brain Response to Serotonergic Medications in ASD". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04145076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*